| MR编号 | DE/H/4913/002 |
|---|
| 药品名称 | ACTAIR 100 IR & 300 IR |
|---|
| 活性成分 | - allergen extract mixture 100.0 IR
- allergen extract mixture 300.0 IR
|
|---|
| 剂型 | Sublingual tablet |
|---|
| 上市许可持有人 | Stallergènes
6, rue Alexis de Tocqueville
92160 Antony
France |
|---|
| 参考成员国 - 产品名称 | Germany (DE) ORYLMYTE 100 IR & 300 IR
PEI.H.12040.02.1 |
|---|
| 互认成员国 - 产品名称 | - Sweden (SE)
- Norway (NO)
Aitmyte - Denmark (DK)
Actair - Poland (PL)
- Belgium (BE)
Orylmyte 100 IR & 300 IR comprimés sublinguaux - Bulgaria (BG)
- Netherlands (NL)
ACTAIR - Czech Republic (CZ)
Actair - Luxembourg (LU)
- Romania (RO)
- Ireland (IE)
- Slovak Republic (SK)
ACTAIR 100 IR sublingválne tablety, ACTAIR 300 IR sublingválne tablety - Austria (AT)
Actair 100 IR + 300 IR Sublingualtabletten - Slovenia (SI)
ACTAIR 100 IR in 300 IR podjezične tablete - France (FR)
- Croatia (HR)
Orlymyte 100 IR + 300 IR sublingvalne tablete - Spain (ES)
- United Kingdom (Northern Ireland) (XI)
- Portugal (PT)
- Italy (IT)
|
|---|
| 许可日期 | 2021/05/28 |
|---|
| 最近更新日期 | 2025/10/10 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Full Dossier
- TypeLevel4：Biological: Other
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|